Last reviewed · How we verify

NCT05074784

Effects of IOPI on Swallowing Function and Functional Status in Geriatric Patients

Status unknown NA Last updated 12 October 2021
What this trial tests

NA trial testing IOPI Therapy in Dysphagia in 84 participants. Status unknown.

Timeline
1 October 2021
Primary endpoint
1 October 2022
1 November 2022

Quick facts

Lead sponsorKhoo Teck Puat Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment84
Start date1 October 2021
Primary completion1 October 2022
Estimated completion1 November 2022

Drugs / interventions tested

Conditions studied

Sponsor

Khoo Teck Puat Hospital

Who can join

Adults 78 to 99, any sex, with Dysphagia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project is an exploratory study that aims to investigate the effects of IOPI therapy on the swallowing function and tongue strength of geriatric patients in a geriatric ward in an acute hospital. Its secondary aim is to investigate the correlation between IOPI readings and functional status. The result of this study could help to improve current practice of dysphagia intervention in the geriatric population. If results are significant, there will be research evidence to put forth a change to work processes for speech therapists. IOPI will be more widely used in the clinical context and will then result in better functional outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Dysphagia

Currently open trials in the same condition.

Other Khoo Teck Puat Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05074784.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing